An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301).
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
75 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site 403
Plovdiv, Bulgaria
- Site 400
Sofia, Bulgaria
- Site 404
Sofia, Bulgaria
- Site 401
Varna, Bulgaria
- Site 402
Veliko Tarnovo, Bulgaria
- Site 110
Montreal, Quebec, Canada
- Site 122
Santiago, Chile
- Site 123
Temuco, Chile
- Site 411
Prague, Czechia
- Site 133
Saint-Herblain, France
- Site 423
Budapest, Hungary
- Site 421
Kaposvár, Hungary
- Site 422
Pécs, Hungary
- Site 156
Ahmedabad, Gujarat, India
- Site 151
Nashik, Maharashtra, India
- Site 153
Pune, Maharashtra, India
- Site 191
Jaipur, Rajasthan, India
- Site 152
Vellore, Tamil Nadu, India
- Site 158
Lucknow, Uttar Pradesh, India
- Site 150
Kolkata, West Bengal, India
- Site 154
Delhi, India
- Site 160
Arezzo, Italy
- Site 161
Pavia, Italy
- Site 162
Roma, Italy
- Site 432
Bialystok, Poland
- Site 434
Bydgoszcz, Poland
- Site 431
Gdansk, Poland
- Site 435
Olsztyn, Poland
- Site 433
Poznan, Poland
- Site 430
Warsaw, Poland
- Site 436
Warsaw, Poland
- Site 444
Brasov, Romania
- Site 440
Bucharest, Romania
- Site 441
Bucharest, Romania
- Site 443
Bucharest, Romania
- Site 442
Timișoara, Romania
- Site 459
Ufa, Bashkortostan Republic, Russia
- Site 451
Chelyabinsk, Russia
- Site 452
Kazan', Russia
- Site 453
Moscow, Russia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2010
- Primary completion
- 31 Jul 2014
- Completion
- 31 Jul 2014
- Last update posted
- 5 Oct 2020
- Registered enrollment
- 277
- Registry id
- NCT01076010
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.